BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2198859)

  • 1. [Neurocysticercosis. II. Evaluation of treatment with praziquantel].
    Takayanagui OM
    Arq Neuropsiquiatr; 1990 Mar; 48(1):11-5. PubMed ID: 2198859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurocysticercosis and praziquantel: long-term development in 100 patients].
    Spina-França A; Nóbrega JP; Machado LR; Livramento JA
    Arq Neuropsiquiatr; 1989 Dec; 47(4):444-8. PubMed ID: 2634386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of neurocysticercosis with low-dose praziquantel.
    Pun KK; Wong WT
    Trop Geogr Med; 1984 Sep; 36(3):303-4. PubMed ID: 6506211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel.
    Takayanagui OM; Jardim E
    Arch Neurol; 1992 Mar; 49(3):290-4. PubMed ID: 1536632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocysticercosis treated with praziquantel. Long-term follow-up of a case.
    Mancuso P; Chiaramonte I; Tropea R
    J Neurosurg Sci; 1991; 35(3):157-60. PubMed ID: 1774596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.
    Sotelo J; del Brutto OH; Penagos P; Escobedo F; Torres B; Rodriguez-Carbajal J; Rubio-Donnadieu F
    J Neurol; 1990 Apr; 237(2):69-72. PubMed ID: 2192018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis.
    van Dellen JR; McKeown CP
    Neurosurgery; 1988 Jan; 22(1 Pt 1):92-6. PubMed ID: 3344093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Praziquantel in the treatment of neurocysticercosis: long-term follow-up.
    Sotelo J; Torres B; Rubio-Donnadieu F; Escobedo F; Rodriguez-Carbajal J
    Neurology; 1985 May; 35(5):752-5. PubMed ID: 3990975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the therapeutic efficacy of praziquantel against human cysticercosis.
    Rim HJ; Joo KH
    Acta Leiden; 1989; 57(2):235-45. PubMed ID: 2489002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of praziquantel levels in cerebrospinal fluid and plasma in patients with cysticercosis of the central nervous system treated with praziquantel].
    Jia JY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):174-6, 189-90. PubMed ID: 1889331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of praziquantel in neurocysticercosis.
    Spina-França A; Nobrega JP; Livramento JA; Machado LR
    Tropenmed Parasitol; 1982 Mar; 33(1):1-4. PubMed ID: 7101435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurocysticercosis and praziquantel. II. Evaluation of results in 20 patients].
    Spina-França A; Nóbrega JP
    Arq Neuropsiquiatr; 1981 Sep; 39(3):279-85. PubMed ID: 7325867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CT follow-up of neurocysticercosis treated with praziquantel].
    Schwartz A; Aulich A; Hammer B
    Radiologe; 1987 May; 27(5):237-42. PubMed ID: 3615856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of neurocysticercosis: is praziquantel the new hope?
    Moodley M; Moosa A
    Lancet; 1989 Feb; 1(8632):262-3. PubMed ID: 2563422
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of neurocysticercosis.
    Joubert J; Jenni WK
    S Afr Med J; 1990 Jan; 77(1):27-30. PubMed ID: 2294609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praziquantel therapy in childhood neurocysticercosis.
    Kalra V; Deorari AK; Goulatia RK
    Indian Pediatr; 1987 Dec; 24(12):1095-8. PubMed ID: 3450660
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term results of praziquantel therapy in neurocysticercosis.
    Robles C; Sedano AM; Vargas-Tentori N; Galindo-Virgen S
    J Neurosurg; 1987 Mar; 66(3):359-63. PubMed ID: 3819831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.
    Jung H; Hurtado M; Sanchez M; Medina MT; Sotelo J
    Clin Neuropharmacol; 1990 Dec; 13(6):559-64. PubMed ID: 2276121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Praziquantel therapy in neurocysticercosis.
    Aggarwal SP; Sabharwal BD
    J Assoc Physicians India; 1995 May; 43(5):356-7. PubMed ID: 9081969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.